ANCA-ASSOCIATED PRIMARY NECROTIZING VASCULITIDES

Clinical trials for ANCA-ASSOCIATED PRIMARY NECROTIZING VASCULITIDES explained in plain language.

Never miss a new study

Get alerted when new ANCA-ASSOCIATED PRIMARY NECROTIZING VASCULITIDES trials appear

Sign up with your email to follow new studies for ANCA-ASSOCIATED PRIMARY NECROTIZING VASCULITIDES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Heart-Protecting pill tested for rare autoimmune disease

Disease control Completed

This study tested whether the cholesterol-lowering drug rosuvastatin (Crestor) could reduce hidden artery plaque and prevent heart attacks or strokes in people with ANCA-associated vasculitis, a rare autoimmune disease. The trial involved 121 adult patients whose vasculitis was i…

Matched conditions: ANCA-ASSOCIATED PRIMARY NECROTIZING VASCULITIDES

Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Apr 02, 2026 05:41 UTC

ANCA-ASSOCIATED PRIMARY NECROTIZING VASCULITIDES

Get alerted when new ANCA-ASSOCIATED PRIMARY NECROTIZING VASCULITIDES trials appear

Heart-Protecting pill tested for rare autoimmune disease